MusclePharm (OTCMKTS:MSLP) Issues Quarterly Earnings Results

MusclePharm (OTCMKTS:MSLP) released its quarterly earnings data on Tuesday. The company reported $0.06 earnings per share for the quarter, reports. The company had revenue of $15.13 million during the quarter.

Shares of OTCMKTS MSLP traded up $0.12 during trading hours on Thursday, hitting $1.12. 76,892 shares of the stock were exchanged, compared to its average volume of 28,972. The company’s 50 day moving average is $0.62 and its 200 day moving average is $0.38. MusclePharm has a one year low of $0.04 and a one year high of $1.16.

About MusclePharm

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of powders, capsules, tablets, and gels. Its MusclePharm brand product portfolio include combat protein powder and combat crunch protein bars; essentials supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products; and non-genetically modified organism sports performance products with organic ingredients, plant-based proteins, and natural caffeine sources for use in the various stages of the workout.

Further Reading: Most Volatile Stocks – What Investors Need to Know to Maximize ROI

Earnings History for MusclePharm (OTCMKTS:MSLP)

Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with's FREE daily email newsletter.